Nebulized activated protein C in a paediatric patient with severe acute respiratory distress syndrome secondary to H1N1 influenza

British Journal of Anaesthesia

Volumn 107, Issue 5, 2011, Pages 818-819

  Pestana D ^a   De La Oliva, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; OSELTAMIVIR; STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; DRUG TREATMENT FAILURE; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HUMAN; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LETTER; LUNG INJURY; NEBULIZATION; NONINVASIVE VENTILATION; OXYGEN SATURATION; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RHABDOMYOSARCOMA; SCHOOL CHILD; THROMBOCYTE COUNT;

EID: 80054114698     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer316     Document Type: Letter

References (9)

1. Altmann M, Fiebig L, Sokya J, von Kries R, Dehnert M, Haas W. Severe cases of pandemic (H1N1) 2009 in children, Germany. Emerg Infect Dis 2011;17:186-92
2. Martín-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) v influenza A infection. Intensive Care Med 2011;37:272-83
3. Meduri GU, Marik PE, Chrousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34:61-9
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
5. Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomized controlled trial. Lancet 2007;369:836-43
6. Liu KD, Looney MR, Matthay MA. Inhaled activated protein C: a novel therapy for acute lung injury? Crit Care 2009;13:150
7. Arnold JH, Anas NG, Luckett P, et al. High-frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med 2000;28:3913-9
8. Pestaña D, de Blas M, Somoza C, Royo C. Activated protein C nebulization in severe late acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:280
9. Liu KD, Levitt J, Zhuo H, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178:618-23